Form 8-K - Current report:
SEC Accession No. 0001104659-25-048210
Filing Date
2025-05-14
Accepted
2025-05-14 09:03:50
Documents
20
Period of Report
2025-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259573d4_8k.htm   iXBRL 8-K 44092
2 EXHIBIT 4.1 tm259573d4_ex4-1.htm EX-4.1 103266
3 EXHIBIT 10.1 tm259573d4_ex10-1.htm EX-10.1 256596
4 EXHIBIT 10.2 tm259573d4_ex10-2.htm EX-10.2 55969
5 EXHIBIT 10.3 tm259573d4_ex10-3.htm EX-10.3 129834
6 EXHIBIT 99.1 tm259573d4_ex99-1.htm EX-99.1 13034
10 GRAPHIC tm259573d4_8kimg001.jpg GRAPHIC 16103
11 GRAPHIC tm259573d4_ex99-1img001.jpg GRAPHIC 7442
  Complete submission text file 0001104659-25-048210.txt   973183

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mtva-20250508.xsd EX-101.SCH 3017
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtva-20250508_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtva-20250508_pre.xml EX-101.PRE 22360
22 EXTRACTED XBRL INSTANCE DOCUMENT tm259573d4_8k_htm.xml XML 3673
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 25942987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)